Clinical Trial

A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a phase I, open-label, single-arm study conducted to evaluate the efficacy, safety and PK of CGC738 in the treatment of advanced clear cell renal cell carcinoma (ccRCC).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-05.
Trial Details
NCT Number NCT06870279
Lead Sponsor RenJi Hospital
Conditions Advanced Clear Cell Renal Cell Carcinoma
Enrollment 28 participants
Start Date 2025-05-25
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-24